Gene · 7317
Papers2,562
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,562
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tracing the Clonal Origin of VEXAS: Insights from cases of myelofibrosis with concurrent UBA1 and JAK2 V617F mutation. | Leuk Res | 2026 | 42822249 | PubTator, text mining | PubMed |
| A novel mechanism of ubiquitin-charging a bivalent E2:RING E3 complex. | bioRxiv | 2026 | 42818655 | PubTator, text mining | PubMed |
| VEXAS Syndrome Associated With a Non-Canonical UBA1 p.Ala478Ser Variant: Diagnostic and Clinical Implications. | Int J Lab Hematol | 2026 | 42816060 | PubTator, text mining | PubMed |
| Steric Gating Contributes to the Preferential Ubiquitin Charging of BIRC6 by UBA6 versus UBA1. | Nat Commun | 2026 | 42811028 | PubTator, text mining | PubMed |
| Endotheliopathy and VWF-ADAMTS13 axis dysfunction in VEXAS thrombogenicity. | Blood | 2026 | 42809655 | PubTator, text mining | PubMed |
| Fluorophore placement and size impact E2 ubiquitination efficiency. | Biochem J | 2026 | 42770861 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Challenge: VEXAS Syndrome with Multisystem Inflammation and Myelodysplasia: A Case Report. | Mediterr J Rheumatol | 2026 | 42756639 | PubTator, text mining | PubMed |
| Acute Fulminant Systemic Granulocytic Vasculitis Involving Arteries and Veins in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: An Autopsy Case Report. | Pathol Int | 2026 | 42747349 | PubTator, text mining | PubMed |
| Vexas Syndrome: A Multisystem Challenge with Sweet Syndrome and Myelodysplastic Syndrome. | Eur J Case Rep Intern Med | 2026 | 42725115 | PubTator, text mining | PubMed |
| Human Monocytic Models Reveal Genotype-Dependent Inflammatory Programs in VEXAS Syndrome. | Arthritis Rheumatol | 2026 | 42703964 | PubTator, text mining | PubMed |
| UBA1 enhances phagocytosis by suppressing CD47 expression in small cell lung cancer. | Front Oncol | 2026 | 42694822 | PubTator, text mining | PubMed |
| Clinical and molecular spectrum of VEXAS with multiple UBA1 variants: case study and literature review. | Am J Clin Pathol | 2026 | 42692534 | PubTator, text mining | PubMed |
| VEXAS Syndrome：Report of One Case. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2026 | 42660847 | PubTator, text mining | PubMed |
| An Italian cartography of VEXAS-related thrombosis. | Hemasphere | 2026 | 42609713 | PubTator, text mining | PubMed |
| VEXAS Syndrome: A Comprehensive Review for Dermatologists Part 2: Work-up, Diagnosis, Treatment, and Prognosis. | J Am Acad Dermatol | 2026 | 42607950 | PubTator, text mining | PubMed |
| Discovery and Characterization of Inhibitors of Ubiquitin-Like Modifier Activating Enzyme 5 (UBA5): Targeting the UFMylation Pathway in Cancer and Neurodegenerative Diseases. | ACS Chem Biol | 2026 | 42607158 | PubTator, text mining | PubMed |
| Vexas Syndrome Without Macrocytosis: A Case Highlighting an Expanding Clinical Phenotype and Diagnostic Delay. | Cureus | 2026 | 42571568 | PubTator, text mining | PubMed |
| Retraction notice to "Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation" [JAAD Case Reports 68 (2026) 105-107]. | JAAD Case Rep | 2026 | 42558322 | PubTator, text mining | PubMed |
The ubiquitin-activating enzyme inhibitor TAK-243 activates store-operated Ca2+ channels independently of endoplasmic reticulum Ca2+ stores and enhances mitochondrial Ca2+ buffering capacity in DU-145 human prostate cancer cells. | Biochim Biophys Acta Mol Cell Res | 2026 | 42546775 | PubTator, text mining | PubMed |
| Newly Diagnosed VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome in a Patient Presenting With Legionella Pneumonia. | Cureus | 2026 | 42535209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7317/papers